Progression-Free Survival Outcome is Independent of Objective Response in Patients with Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Treated with Palbociclib Plus Letrozole Compared to Letrozole: Analysis from PALOMA-2

Title

Progression-Free Survival Outcome is Independent of Objective Response in Patients with Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Treated with Palbociclib Plus Letrozole Compared to Letrozole: Analysis from PALOMA-2

Authors

Keywords

advanced breast cancer, cyclin-dependent kinase, ER+/HER2–, letrozole, objective response, palbociclib

Journal

Clinical Breast Cancer

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2019-09-05

DOI

10.1016/j.clbc.2019.08.009